Teva, Others Seek To Nix Retailers' Pay-For-Delay Suits
Teva Pharmaceuticals USA Inc., Boehringer Ingelheim Pharmaceuticals Inc. and other pharmaceutical companies accused in multidistrict litigation of engaging in a pay-for-delay scheme over the stroke drug Aggrenox told a Connecticut federal...To view the full article, register now.
Already a subscriber? Click here to view full article